Ayr Wellness Inc. (AYRWF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ayr Wellness Inc. (AYRWF) trades at $0.01 with AI Score 47/100 (Grade C). Ayr Wellness Inc. is a vertically integrated cannabis multi-state operator focused on cultivating, manufacturing, and retailing cannabis products. Market cap: $1.42M, Sector: Healthcare.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for AYRWF: AYRWF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AYRWF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
AYRWF: the 1 perspectives are evenly split.
How is this calculated? →Ayr Wellness Inc. (AYRWF) Healthcare & Pipeline Overview
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products as a vertically-integrated, multi-state operator. With a focus on branded cannabis packaged goods, the company operates dispensaries and offers support services within the evolving cannabis market, facing competition and regulatory changes.
What Is the Investment Thesis for AYRWF?
Ayr Wellness Inc. presents a speculative investment opportunity within the rapidly evolving cannabis industry. The company's vertically integrated operations and multi-state presence offer potential for growth as cannabis legalization expands. However, negative profitability (Profit Margin: -80.9%) and a high beta of 1.07 indicate significant risk. Key catalysts include expansion into new markets and increased operational efficiency. Investors should closely monitor regulatory changes, competition, and the company's ability to achieve profitability. The company's strategy to grow its portfolio of branded cannabis packaged goods could drive future revenue growth, but success depends on effective brand management and market acceptance.
Based on FMP financials and quantitative analysis
AYRWF Key Highlights
- Ayr Wellness Inc. operates as a vertically-integrated cannabis multi-state operator, controlling the entire value chain from cultivation to retail.
- The company's gross margin stands at 33.3%, reflecting its ability to generate revenue after accounting for the cost of goods sold.
- Ayr Wellness Inc. reported a negative profit margin of -80.9%, indicating substantial losses relative to revenue.
- The company's beta of 1.07 suggests that its stock price is slightly more volatile than the overall market.
- As of July 26, 2022, Ayr Wellness Inc. operated 49 dispensaries across multiple states, demonstrating its expanding retail footprint.
Who Are AYRWF's Competitors?
AYRWF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BQST BioQuest Corp. | $0.51 | +674.24% | $5.87M | 49 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AYRWF's Key Strengths?
- Vertically integrated operations
- Multi-state operator status
- Established retail presence
- Focus on branded products
What Are AYRWF's Weaknesses?
- Negative profitability
- High operating expenses
- Dependence on regulatory approvals
- Limited brand recognition compared to larger competitors
What Could Drive AYRWF Stock Higher?
- Expansion into new states as cannabis legalization progresses.
- Development and launch of new branded cannabis products.
- Efforts to improve operational efficiency and reduce costs.
What Are the Key Risks for AYRWF?
- Financial-distress signal — its Altman Z-Score of -1.63 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-62.8%) — the business is not currently generating profit on shareholder capital.
- Changes in cannabis regulations could negatively impact the company's operations.
- Intense competition in the cannabis industry could erode market share and profitability.
- Economic downturn could reduce consumer spending on cannabis products.
- Negative profit margins and high operating expenses could strain the company's financial resources.
What Are the Growth Opportunities for AYRWF?
- Expansion into New Markets: As cannabis legalization continues to spread across the United States, Ayr Wellness has the opportunity to expand its operations into new states. Each new state represents a potential market with millions of consumers. Successful market entry requires navigating complex regulatory frameworks and establishing efficient supply chains. The timeline for expansion depends on the pace of legalization in individual states, but the long-term potential is significant.
- Increased Operational Efficiency: Improving operational efficiency can significantly boost Ayr Wellness's profitability. By streamlining cultivation processes, optimizing manufacturing, and enhancing retail operations, the company can reduce costs and increase margins. Investments in technology and automation can play a key role in achieving these improvements. The impact of increased efficiency will be seen in improved financial performance over the next several years.
- Development of Branded Products: Ayr Wellness can drive growth by developing and marketing its own branded cannabis products. Strong brands can command premium prices and foster customer loyalty. This requires investment in product development, marketing, and distribution. The success of branded products will depend on consumer preferences and the company's ability to differentiate its offerings from competitors. This is an ongoing opportunity with long-term potential.
- Strategic Acquisitions: Ayr Wellness can pursue strategic acquisitions to expand its market presence and acquire new capabilities. Acquiring smaller cannabis companies or dispensaries can provide access to new markets and customers. Successful acquisitions require careful due diligence and integration. The timing and impact of acquisitions are difficult to predict, but they can be a significant driver of growth.
- Focus on High-Margin Products: Ayr Wellness can improve its profitability by focusing on high-margin cannabis products, such as concentrates, edibles, and vaporizer products. These products typically command higher prices than raw cannabis flower. By shifting its product mix towards these higher-margin offerings, the company can increase its overall profitability. This strategy requires investment in product development and marketing, but the potential rewards are significant.
What Opportunities Does AYRWF Have?
- Expansion into new states
- Increased legalization of cannabis
- Development of new products and brands
- Strategic acquisitions
What Threats Does AYRWF Face?
- Intense competition
- Changing regulations
- Price volatility
- Economic downturn
What Are AYRWF's Competitive Advantages?
- Vertically integrated operations provide control over the supply chain and potentially lower costs.
- Multi-state operator status allows for diversification and expansion into new markets.
- Brand recognition and customer loyalty in established markets.
What Does AYRWF Do?
Ayr Wellness Inc., established in 2017 and headquartered in Miami, Florida, operates as a vertically integrated cannabis multi-state operator (MSO). The company cultivates, manufactures, and retails cannabis products, including concentrates, edibles, and vaporizer products. Ayr Wellness provides administrative, consulting, and operations support services to licensed cannabis companies. As of July 26, 2022, Ayr Wellness operated 49 dispensaries. Formerly known as Ayr Strategies Inc., the company rebranded to Ayr Wellness Inc. in February 2021 to better reflect its focus on the cannabis industry. Ayr Wellness aims to create a portfolio of branded cannabis packaged goods, positioning itself as a key player in the expanding cannabis market across multiple states. The company's vertically integrated model allows it to control the entire value chain, from cultivation to retail, potentially enhancing profitability and ensuring product quality.
What Products and Services Does AYRWF Offer?
- Cultivates cannabis plants in controlled environments.
- Manufactures cannabis products, including concentrates, edibles, and vaporizer products.
- Retails cannabis products through its network of dispensaries.
- Develops and markets branded cannabis packaged goods.
- Provides administrative, consulting, and operations support services to licensed cannabis companies.
- Operates 49 dispensaries as of July 2022.
How Does AYRWF Make Money?
- Vertically integrated operations, controlling the entire value chain from cultivation to retail.
- Generates revenue from the sale of cannabis products through its dispensaries.
- Provides support services to other cannabis companies for a fee.
What Industry Does AYRWF Operate In?
Ayr Wellness Inc. operates within the rapidly growing cannabis industry, which is characterized by evolving regulations and increasing consumer acceptance. The market is highly competitive, with numerous multi-state operators vying for market share. Key trends include the increasing legalization of cannabis for both medical and recreational use, driving market expansion. Ayr Wellness competes with companies like AUSAF, AYURF, BQST, CBIH, and CLCFF. The company's success depends on its ability to navigate regulatory complexities, establish strong brands, and efficiently manage its operations.
Who Are AYRWF's Key Customers?
- Adult-use cannabis consumers in states where recreational cannabis is legal.
- Medical cannabis patients in states where medical cannabis is legal.
- Licensed cannabis companies seeking operational support services.
Ayr Wellness Inc. Financial Trajectory
Ayr Wellness Inc. (AYRWF) reported $107.3M in revenue for Q1 2025, a decline of 5.8% compared to the prior quarter. The company recorded a net loss of $57.1M, with diluted EPS of $-0.49. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, AYRWF averaged $-0.67 in diluted EPS.
Company Profile
Ayr Wellness Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Miami, US. The company is led by CEO Scott J. Davido. AYRWF has traded publicly since 2020.
How Ayr Wellness Inc. Is Valued
Ayr Wellness Inc. carries a market capitalization of $1.42M, placing it in the micro-cap category. Relative to its peer group, AYRWF's quantitative score of 47/100 is below the peer average of 64/100.
ROE -63%Key Financial Metrics
Return on equity for Ayr Wellness Inc. stands at -62.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -17.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -51.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.49 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
Ayr Wellness Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.63 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Ayr Wellness Inc. revenue of about $442.8M for fiscal 2026, with EPS near $-1.16.
AYRWF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations
- Multi-state operator status
- Established retail presence
- Focus on branded products
Bear Case
- Negative profitability
- High operating expenses
- Dependence on regulatory approvals
- Limited brand recognition compared to larger competitors
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2025 | $107M | -$57M | -$0.49 |
| Q4 2024 | $114M | -$164M | -$1.40 |
| Q3 2024 | $114M | -$51M | -$0.44 |
| Q2 2024 | $117M | -$39M | -$0.34 |
Based on FMP financials and quantitative analysis
AYRWF Latest News
-
AYR Wellness Announces Closing of Florida, New Jersey and Nevada Operations Transfer to Arboretum
globenewswire.com · Jun 2, 2026
AYRWF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AYRWF.
Price Targets
Wall Street price target analysis for AYRWF.
AYRWF MoonshotScore
What does this score mean?
The MoonshotScore rates AYRWF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Scott J. Davido
Unknown
Information about Scott J. Davido's background is not available in the provided data. Without additional context, it is impossible to provide a detailed career history, education, or previous roles.
Track Record: Information about Scott J. Davido's track record is not available in the provided data. Without specific achievements, strategic decisions, or company milestones under his leadership, it is impossible to assess his performance.
AYRWF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ayr Wellness Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, and investors should exercise caution due to the potential for higher risk and lower transparency compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with distressed financials, early-stage ventures, or those that choose not to meet stricter listing requirements.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Lower liquidity
- Higher price volatility
- Potential for fraud or manipulation
- Regulatory uncertainty
- Verify the company's financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company has been in operation since 2017.
- Operates a vertically integrated business model.
- Operates 49 dispensaries as of July 2022.
- Company has a substantial number of employees (2440).
- Company was formerly known as Ayr Strategies Inc.
Ayr Wellness Inc. Healthcare Stock: Key Questions Answered
What does Ayr Wellness Inc. do?
Ayr Wellness Inc. operates as a vertically integrated cannabis multi-state operator, cultivating, manufacturing, and retailing cannabis products. The company's business model encompasses the entire value chain, from cultivation to retail sales, allowing it to control product quality and potentially improve margins. Ayr Wellness focuses on branded cannabis packaged goods, offering a range of products including concentrates, edibles, and vaporizer products. The company also provides support services to other licensed cannabis companies, further diversifying its revenue streams. As of July 2022, Ayr Wellness operated 49 dispensaries.
What do analysts say about AYRWF stock?
Analyst opinions on AYRWF stock are not provided in the source data. Without this information, it is impossible to provide a summary of analyst consensus, key valuation metrics, or growth considerations. Investors should consult with financial professionals and conduct their own research to form an informed opinion about the stock's potential. Factors to consider include the company's financial performance, industry trends, and regulatory environment.
What are the main risks for AYRWF?
Ayr Wellness Inc. faces several risks inherent to the cannabis industry and its specific business model. Regulatory changes pose a significant threat, as evolving laws and regulations can impact the company's ability to operate and expand. Intense competition from other multi-state operators and smaller cannabis companies could erode market share and profitability. The company's negative profit margins and high operating expenses raise concerns about its financial sustainability. Economic downturns could reduce consumer spending on cannabis products, further impacting revenue.
What are the key factors to evaluate for AYRWF?
Ayr Wellness Inc. (AYRWF) holds an AI score of 47/100 (low). Not financial advice.
How frequently does AYRWF data refresh on this page?
AYRWF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AYRWF's recent stock price performance?
Ayr Wellness Inc. (AYRWF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AYRWF overvalued or undervalued right now?
Valuing Ayr Wellness Inc. (AYRWF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AYRWF?
Before investing in Ayr Wellness Inc. (AYRWF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2026-03-15.
- OTC market data may be less reliable than major exchange data.
- Analyst opinions are not available in the provided source data.